Advertisement
Home »

Predicting Mirabegron Treatment Response in Patients with Overactive Bladder: A Post Hoc Analysis of Data from Clinical Trials.

May 01, 2023

ABOUT THE EXPERTS

  • Rano Matta

    Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.

    Refik Saskin

    Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.

    Sarah Neu

    Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.

    Jennifer A Locke

    Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.

    Alice Kowalczyk

    Astellas Pharma Canada, Inc., Markham, Canada.

    Achim Steup

    Astellas Pharma US, Inc., Northbrook, IL, USA.

    Sender Herschorn

    Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada. Electronic address: s.herschorn@utoronto.ca.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement